Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — November 2025

Biotek-snakken — November 2025

Planlagt Fastgjort Låst Flyttet Biotek-snakken
75 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #12

    Det er en virkelig smuk gestus LP90...

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #13

      Godmorgen.

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #14

        Godmorgen 🙂

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #15

          Sukkeralf, hvad er din read på Jazz at de modtager alle 920 patienter. Er det kun for at speede read out op eller ?

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #16

            Der er stadigvæk størts sandsynlighed for at det blot er for at speede read out op. Men ctrl arm har måske også klaret sig bedre end i keynote-811 grundet bedre AE mgm, og andre patients kriterier.

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #17

              Lidt bagud med at høre diverse CCs - hørte Zymes i morges og min første tanke var, at bare nu ikke udskydelsen af data er fordi de tager alle patienter med. Man blev jo ikke klogere af deres CC, så vil se om jeg får tid til at høre Jazz´s CC i aften eller i morgen.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #18

                Bliver så træt af disse ting der indimellem opstår og man aldrig kan få en reel forklaring, når det altid medfører usikkerhed efterfølgende. Dejligt at Zymes trods alt stiger i dag, for synes deres CC ellers var ganske godt. Hvor jeg tidligere ikke havde ret meget mod på deres pipeline, så har seneste data fra deres FRalfa studie vendt lidt op og ned på det…….og Janssen der er videre i fase III med KLK2/CD3.

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #19

                  Moving to Slide 14. Our next major catalyst is the top line readout of the Phase III zanidatamab HERIZON-GEA-01 trial. As we announced today and after alignment with FDA, we have updated the intent-to-treat patient population for PFS to now include the fully enrolled patient population, increasing the PFS cohort from the targeted 714 to 920 patients, which is the actual number of enrolled patients as detailed on clinicaltrials.gov. As a reminder, we previously took the opportunity to expand the

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #20

                    the patient population for the overall survival analysis by expanding the sample size for that endpoint. With progression events accruing more slowly than anticipated, combined with the study being fully enrolled with sufficient follow-up on enrolled patients, we aligned with the FDA to conduct the PFS analysis on the entire randomized patient population. Following this change, we continue to have robust powering to show a benefit for PFS, and we remain highly confident that we will announce

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #21

                      top line results later this year, consistent with our prior guidance.

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        lahn1
                        wrote on sidst redigeret af
                        #22

                        Det store fald i fredags var nok twitter rygter om at ctrl armen har klaret sig bedre end ventet. Men det tror jeg ikke holder.

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #23

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #24

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #25

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • F Offline
                                F Offline
                                Fandel
                                wrote on sidst redigeret af
                                #26

                                Er der noget nyt om Saniona, siden den lige pludselig faldt så meget?

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  Jazzz
                                  wrote on sidst redigeret af
                                  #27

                                  Intet nyt.. Svenske Affairsverden ævler lidt om at de synes den er steget meget og Biotek jo er risikabelt, men pipeline er go.. osv osv.. så lidt ævle bævle: Anbefaler Neutral.. (hvad det så end betyder).. kan ikke finde anden årsag..

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    Jazzz
                                    wrote on sidst redigeret af
                                    #28

                                    Her er artiklen fra Marketscreener..

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      Jazzz
                                      wrote on sidst redigeret af
                                      #29

                                      https://www.marketscreener.com/news/affarsvarlden-issues-neutral-recommendation-for-saniona-ce7d5fdcd18ef723#:~:text=Published on 11/13/2025,time%2C" the magazine writes.

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #30

                                        Tak Jazzz...

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #31

                                          Bioporto gennemfører fuldtegnet emission på 43 mio kr. https://proinvestor.com/investornyt/1383022/bioporto-gennemforer-fuldtegnet-emission-pa-43-mio-kr

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper